Premium
Cutaneous C rohn's disease treated with infliximab and 4 years of follow up
Author(s) -
Yoong Corinne,
Schofield Clare,
Rodins Karl,
Faulkner Catherine
Publication year - 2014
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.12069
Subject(s) - infliximab , medicine , disease , dermatology , gastroenterology , surgery
Metastatic C rohn's disease ( MCD ) is a rare, non‐contiguous cutaneous manifestation of C rohn's disease. To date, there have been only four reports in the literature of an effective treatment of this condition with infliximab and there are no long‐term follow‐up studies on adult MCD patients treated with infliximab. We present a case of MCD treated with infliximab with 4.5 years of follow up.